{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:43:56Z","timestamp":1792637036993,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Swiss National Science Foundation","award":["326000-121314\/1"],"award-info":[{"award-number":["326000-121314\/1"]}]},{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jchromb.2020.122160","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:30:52Z","timestamp":1589740252000},"page":"122160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Validation and clinical application of a multiplex high performance liquid chromatography \u2013 tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections"],"prefix":"10.1016","volume":"1157","author":[{"given":"L.A.","family":"Decosterd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ternon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cruchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Guignard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lahrichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lamoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Eggimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Csajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Buclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jchromb.2020.122160_b0005","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jchromb.2020.122160_b0010","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1128\/AAC.01149-05","article-title":"Prospective determination of plasma imipenem concentrations in critically ill children","volume":"50","author":"Giannoni","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2020.122160_b0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/AAC.00891-08","article-title":"Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies","volume":"53","author":"Lamoth","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2020.122160_b0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijantimicag.2010.01.018","article-title":"Daily serum piperacillin monitoring is advisable in critically ill patients","volume":"35","author":"Blondiaux","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jchromb.2020.122160_b0025","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2020.122160_b0030","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/jac\/dky370","article-title":"Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections","volume":"73","author":"Burger","year":"2018","journal-title":"J. Antimicrobial Chemother."},{"key":"10.1016\/j.jchromb.2020.122160_b0035","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/cc8941","article-title":"Prospective monitoring of cefepime in intensive care unit adult patients","volume":"14","author":"Chapuis","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.jchromb.2020.122160_b0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijantimicag.2009.06.001","article-title":"High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction","volume":"34","author":"Lamoth","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jchromb.2020.122160_b0045","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.01595-08","article-title":"High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function","volume":"54","author":"Lamoth","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1649\u20131650","key":"10.1016\/j.jchromb.2020.122160_b0050","first-page":"1652","article-title":"Therapeutic drug monitoring: clinical practice","volume":"4","author":"Widmer","year":"2008","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.jchromb.2020.122160_b0055","first-page":"1644","article-title":"Principles of therapeutic drug monitoring","volume":"4","author":"Widmer","year":"2008","journal-title":"Rev. Med. Suisse"},{"key":"10.1016\/j.jchromb.2020.122160_b0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trac.2015.11.026","article-title":"LC-MS\/MS for Therapeutic Drug Monitoring of anti-infective drugs","volume":"84","author":"Veringa","year":"2016","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2020.122160_b0065","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1515\/cclm-2016-0700","article-title":"The use of liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of antibiotics in cancer patients","volume":"55","author":"El-Najjar","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2020.122160_b0070","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/AAC.00533-11","article-title":"Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring","volume":"55","author":"Verdier","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2020.122160_b0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchromb.2014.04.029","article-title":"Simultaneous determination of seven beta-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies","volume":"960","author":"Sime","year":"2014","journal-title":"J. Chromatogr. B, Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122160_b0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jpba.2013.11.004","article-title":"Simultaneous analysis of antibiotics in biological samples by ultra high performance liquid chromatography-tandem mass spectrometry","volume":"89","author":"Cazorla-Reyes","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122160_b0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jchromb.2013.09.009","article-title":"Simultaneous determination of selected chemotherapeutics in human whole blood by molecularly imprinted polymers coated solid phase microextraction fibers and liquid chromatography-tandem mass spectrometry","volume":"940","author":"Szultka","year":"2013","journal-title":"J. Chromatogr. B, Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122160_b0090","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jchromb.2011.03.001","article-title":"Simultaneous determination of eight beta-lactam antibiotics in human serum by liquid chromatography-tandem mass spectrometry","volume":"879","author":"Ohmori","year":"2011","journal-title":"J. Chromatogr. B, Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122160_b0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1179\/1973947814Y.0000000209","article-title":"Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"27","author":"Barco","year":"2015","journal-title":"J. Chemother."},{"key":"10.1016\/j.jchromb.2020.122160_b0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/CCLM.2011.005","article-title":"Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application","volume":"49","author":"Verdier","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2020.122160_b0105","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00216-010-3639-2","article-title":"Daptomycin determination by liquid chromatography-mass spectrometry in peritoneal fluid, blood plasma, and urine of clinical patients receiving peritoneal dialysis treatment","volume":"397","author":"Gika","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2020.122160_b0110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.talanta.2013.07.043","article-title":"Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry","volume":"116","author":"Tsai","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2020.122160_b0115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijantimicag.2012.06.022","article-title":"Quantification of seven beta-lactam antibiotics and two beta-lactamase inhibitors in human plasma using a validated UPLC-MS\/MS method","volume":"40","author":"Carlier","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jchromb.2020.122160_b0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.talanta.2012.10.046","article-title":"Development and validation of a fast and uniform approach to quantify beta-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography electrospray-tandem mass spectrometry","volume":"103","author":"Colin","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2020.122160_b0125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1515\/cclm-2014-0746","article-title":"Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS\/MS method with semi-automated sample preparation","volume":"53","author":"Zander","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2020.122160_b0130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/dta.2253","article-title":"UPLC-MS\/MS method for therapeutic drug monitoring of 10 antibiotics used in intensive care units","volume":"10","author":"El-Najjar","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jchromb.2020.122160_b0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpba.2018.05.015","article-title":"Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma","volume":"157","author":"Hosl","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122160_b0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpba.2018.01.031","article-title":"Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS\/MS method","volume":"152","author":"Paal","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122160_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cca.2017.03.009","article-title":"Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of beta-lactam antibiotic concentration in human plasma","volume":"468","author":"Rigo-Bonnin","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2020.122160_b0150","doi-asserted-by":"crossref","DOI":"10.3791\/58148","article-title":"Multiplex therapeutic drug monitoring by isotope-dilution HPLC-MS\/MS of antibiotics in critical illnesses","author":"Schuster","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jchromb.2020.122160_b0155","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/FTD.0000000000000555","article-title":"Simultaneous determination of cefalexin, cefazolin, flucloxacillin, and probenecid by liquid chromatography-tandem mass spectrometry for total and unbound concentrations in human plasma","volume":"40","author":"Zhang","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2020.122160_b0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2017.09.014","article-title":"A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma","volume":"1065\u20131066","author":"Lefeuvre","year":"2017","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122160_b0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpba.2015.10.008","article-title":"Simultaneous determination of ceftaroline, daptomycin, linezolid and rifampicin concentrations in human plasma by on-line solid phase extraction coupled to high-performance liquid chromatography-tandem mass spectrometry","volume":"118","author":"Gregoire","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122160_b0170","doi-asserted-by":"crossref","first-page":"e01540","DOI":"10.1128\/AAC.01540-17","article-title":"Development of a novel multipenicillin assay and assessment of the impact of analyte degradation: lessons for scavenged sampling in antimicrobial pharmacokinetic study design","volume":"62","author":"Kipper","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2020.122160_b0175","unstructured":"Food and Drug Administration, Bioanalytical Method Guidance, 2018, https:\/\/www.fda.gov\/media\/70858\/download."},{"key":"10.1016\/j.jchromb.2020.122160_b0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jps.2600810324","article-title":"Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies","volume":"81","author":"Shah","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2020.122160_b0185","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation\u2014a revisit with a decade of progress","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jchromb.2020.122160_b0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","article-title":"Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis","volume":"830","author":"Matuszewski","year":"2006","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2020.122160_b0195","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2020.122160_b0200","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1128\/AAC.00404-10","volume":"54","author":"Decosterd","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2020.122160_b0205","unstructured":"https:\/\/www.admin.ch\/opc\/en\/classified-compilation\/20061313\/index.html#a2."},{"key":"10.1016\/j.jchromb.2020.122160_b0210","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/jo00264a028","article-title":"Studies on the structures of imipenem, dehydropeptidase I hydrolyzed imipenem, and related analogues","volume":"54","author":"Ratcliffe","year":"1989","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jchromb.2020.122160_b0215","unstructured":"Assurance Qualit\u00e9 des Analyse de Biologie M\u00e9dicale: Association ASQUALAB, Paris, France, http:\/\/www.asqualab.com\/."},{"key":"10.1016\/j.jchromb.2020.122160_b0220","unstructured":"KKGT (Kwaliteitsbewaking Klinische Geneesmiddelanalyse en Toxicologie, The Hague, The Netherlands), http:\/\/kkgt.nl\/?lang=en."},{"key":"10.1016\/j.jchromb.2020.122160_b0225","unstructured":"INSTAND (Gesellschaft zur F\u00f6rderung der Qualit\u00e4tssicherung in medizinischen Laboratorien e.V.), https:\/\/www.instand-ev.de\/."},{"key":"10.1016\/j.jchromb.2020.122160_b0230","unstructured":"Novartis Pharma AG (Bern, Switzerland), Promotional Information Note, D\u00e9termination des taux plasmatiques de Daptomycine, January 2011."},{"issue":"Suppl B","key":"10.1016\/j.jchromb.2020.122160_b0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/32.suppl_B.103","article-title":"Pharmacokinetics of cefepime: a review","volume":"32","author":"Van der Auwera","year":"1993","journal-title":"J Antimicrob. Ther."}],"updated-by":[{"DOI":"10.1016\/j.jchromb.2022.123497","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000}}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220303949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220303949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T16:59:26Z","timestamp":1615741166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023220303949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":47,"alternative-id":["S1570023220303949"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122160","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and clinical application of a multiplex high performance liquid chromatography \u2013 tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122160"}}